"tyrosine kinase inhibitor" trang 11 - tải miễn phí từ tailieuXANH
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation

SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
9    40    0
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer
10    51    0
Early onset recall pneumonitis during targeted therapy with sunitinib

Early onset recall pneumonitis during targeted therapy with sunitinib
4    51    0
SCMBYK: Prediction and characterization of bacterial tyrosine-kinases based on propensity scores of dipeptides

SCMBYK: Prediction and characterization of bacterial tyrosine-kinases based on propensity scores of dipeptides
15    51    0
EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib
10    68    0
Kháng thuốc ức chế tyrosine kinase thế hệ thứ nhất ở bệnh nhân ung thư phổi không tế bào nhỏ

Kháng thuốc ức chế tyrosine kinase thế hệ thứ nhất ở bệnh nhân ung thư phổi không tế bào nhỏ
9    63    1
Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: A prospective cohort study
9    35    1
Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
9    46    1
EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function

EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function
10    37    1
Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
5    43    1
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma

PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
9    31    1
The expression and prognostic value of the epidermal growth factor receptor family in glioma

The expression and prognostic value of the epidermal growth factor receptor family in glioma
14    47    1
Efficacy and safety of apatinib in the treatment of osteosarcoma: A single-arm meta-analysis among Chinese patients

Efficacy and safety of apatinib in the treatment of osteosarcoma: A single-arm meta-analysis among Chinese patients
11    40    1
EGFR mutation status in Tunisian nonsmall-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

EGFR mutation status in Tunisian nonsmall-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
8    38    1
Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: A case report

Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: A case report
4    29    1
Multiple intraventricular metastases from lung adenocarcinoma with EGFR G719X mutation: A case report

Multiple intraventricular metastases from lung adenocarcinoma with EGFR G719X mutation: A case report
4    46    1
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
8    47    1
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment

Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
7    42    1
Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies

Feasibility of tissue re-biopsy in non-small cell lung cancers resistant to previous epidermal growth factor receptor tyrosine kinase inhibitor therapies
9    43    1
ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition
11    47    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.